Immunome Inc

/Immunome Inc

IPO

Immunome Inc

Biopharmaceutical

We are a biopharmaceutical company utilizing our proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated.

Symbol

IMNM

Price Range
$11.00 - $13.00

Final Shares
2,500,000

Anticipated Date
October 2, 2020

Underwriters
LADENBURG, THALMANN & CO., INC.

This offering is no longer available

To view the prospectus for Immunome Inc IPO, or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC P. O. Box 21154, Mesa, AZ 85277